{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:14:50Z","timestamp":1793999690138,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clinbiochem.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T17:28:17Z","timestamp":1615829297000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS\/NRAS\/BRAF genotyping for metastatic colorectal cancer"],"prefix":"10.1016","volume":"92","author":[{"given":"Fei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6881-9977","authenticated-orcid":false,"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinbiochem.2021.03.005_b0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.03.005_b0010","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.03.005_b0015","first-page":"e153","article-title":"Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis","volume":"16","author":"Tosi","year":"2017","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.clinbiochem.2021.03.005_b0020","doi-asserted-by":"crossref","unstructured":"A.B. Benson, 3rd, A.P. Venook, L. Cederquist, E. Chan, Y.J. Chen, H.S. Cooper, D. Deming, P.F. Engstrom, P.C. Enzinger, A. Fichera, J.L. Grem, A. Grothey, H.S. Hochster, S. Hoffe, S. Hunt, A. Kamel, N. Kirilcuk, S. Krishnamurthi, W.A. Messersmith, M.F. Mulcahy, J.D. Murphy, S. Nurkin, L. Saltz, S. Sharma, D. Shibata, J.M. Skibber, C.T. Sofocleous, E.M. Stoffel, E. Stotsky-Himelfarb, C.G. Willett, C.S. Wu, K.M. Gregory, D. Freedman-Cass, Colon Cancer, Version 1.2017, NCCN Clinical practice guidelines in oncology, J. Natl. Compr. Canc. Netw. 15(3) (2017) 370-398.","DOI":"10.6004\/jnccn.2017.0036"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.03.005_b0025","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/annonc\/mdx125","article-title":"Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients","volume":"28","author":"Vidal","year":"2017","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.03.005_b0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/annonc\/mdx417","article-title":"RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial","volume":"29","author":"Normanno","year":"2018","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.03.005_b0035","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/annonc\/mdx112","article-title":"Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer","volume":"28","author":"Grasselli","year":"2017","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.03.005_b0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jamaoncol.2017.4027","article-title":"Patient-paired sample congruence between 2 commercial liquid biopsy tests","volume":"4","author":"Torga","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.03.005_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/annonc\/mdx504","article-title":"Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer","volume":"29","author":"Siena","year":"2018","journal-title":"Ann. Oncol."},{"issue":"16","key":"10.1016\/j.clinbiochem.2021.03.005_b0050","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"36","author":"Merker","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.03.005_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.03.005_b0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","article-title":"Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies","volume":"22","author":"Bowman","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.clinbiochem.2021.03.005_b0065","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jamaoncol.2018.2297","article-title":"Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors","volume":"4","author":"Ptashkin","year":"2018","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.03.005_b0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell. Stem Cell."},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.03.005_b0075","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1515\/cclm-2019-0142","article-title":"Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients","volume":"57","author":"Wang","year":"2019","journal-title":"Clin.. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.03.005_b0080","doi-asserted-by":"crossref","unstructured":"T. McKerrell, N. Park, T. Moreno, C.S. Grove, H. Ponstingl, J. Stephens, G. Understanding Society Scientific, C. Crawley, J. Craig, M.A. Scott, C. Hodkinson, J. Baxter, R. Rad, D.R. Forsyth, M.A. Quail, E. Zeggini, W. Ouwehand, I. Varela, G.S. Vassiliou, Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis, Cell. Rep. 10(8) (2015) 1239-45.","DOI":"10.1016\/j.celrep.2015.02.005"},{"key":"10.1016\/j.clinbiochem.2021.03.005_b0085","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.03.005_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","article-title":"Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life","volume":"101","author":"Acuna-Hidalgo","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"18","key":"10.1016\/j.clinbiochem.2021.03.005_b0095","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-18-0143","article-title":"False-Positive Plasma Genotyping Due to Clonal Hematopoiesis","volume":"24","author":"Hu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.03.005_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.seminhematol.2016.10.002","article-title":"Clonal hematopoiesis","volume":"54","author":"Jan","year":"2017","journal-title":"Semin. Hematol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.03.005_b0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.03.005_b0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmoldx.2018.09.007","article-title":"A novel multiplex droplet digital PCR assay to identify and quantify KRAS mutations in clinical specimens","volume":"21","author":"Alcaide","year":"2019","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.03.005_b0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/FTD.0000000000000566","article-title":"Circulating cell-free DNA-diagnostic and prognostic applications in personalized cancer therapy","volume":"41","author":"Oellerich","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"17","key":"10.1016\/j.clinbiochem.2021.03.005_b0120","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N. Engl. J. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:56:50Z","timestamp":1757865410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":24,"alternative-id":["S0009912021000746"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.03.005","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS\/NRAS\/BRAF genotyping for metastatic colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}